← Top stories
Market move▲ Bullish for Cupid
Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally
The brief
- Cupid shares surged 178% in 2026, after rising 584% in 2025
- Growing orders and expansion plans drove the rally
- Cupid shareholders are exposed to the stock’s sharp run-up and execution of its expansion plans